Scientists at a London hospital have successfully completed the world's first trial of a drug designed to reverse hearing loss.
The REGAIN trial, at University College London Hospital (UCLH), assessed the efficacy of a drug named LY3056480 in a group of adults with mild to moderate hearing loss.
